Skip to main content

Composite Resins

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Coordination Pharmaceuticals
2 programs
Direct composite resinN/A1 trial
Thermoviscous bulk-fill composite restorationN/A1 trial
Active Trials
NCT03936855Completed54Est. Sep 2018
NCT07518537Not Yet Recruiting70Est. Jul 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Coordination PharmaceuticalsThermoviscous bulk-fill composite restoration
Coordination PharmaceuticalsDirect composite resin

Clinical Trials (2)

Total enrollment: 124 patients across 2 trials

NCT07518537Coordination PharmaceuticalsThermoviscous bulk-fill composite restoration

Bulk-Fill Composite Restorations: Clinical Evaluation

Start: May 2026Est. completion: Jul 202770 patients
N/ANot Yet Recruiting

Clinical Evaluation of Posterior Direct Restoration in Adolescents

Start: Jan 2016Est. completion: Sep 201854 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.